Michael J. Primiano
Pfizer (United States)(US)
Publications by Year
Research Areas
Inflammasome and immune disorders, Monoclonal and Polyclonal Antibodies Research, IL-33, ST2, and ILC Pathways, T-cell and B-cell Immunology, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit(2012)195 cited
- → An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice(2016)189 cited
- → Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation(2016)175 cited
- → Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia(1996)128 cited
- → Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia(1995)92 cited
- → Choroid Plexus Recovery After Transient Forebrain Ischemia: Role of Growth Factors and Other Repair Mechanisms(2000)89 cited
- → N -Acetylcysteine Enhances Hippocampal Neuronal Survival After Transient Forebrain Ischemia in Rats(1995)83 cited
- Preclinical in vitro characterization of anti-CTLA4 therapeutic antibody CP-675,206.(2004)
- → Choroid plexus electrolytes and ultrastructure following transient forebrain ischemia(1995)32 cited
- → Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells(2019)12 cited